Search
for
Sort by
Research 30 of 145
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata: A Complex Cytokine Driven Disease
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management